Vetzel M[au] - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2006	2
2007	4
2008	1
2009	1
2010	1
2011	2
2014	2
2016	1
2017	2
2018	1
2019	2
2020	1
2024	0

1

Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic.

Reddy JA, Dorton R, Bloomfield A, Nelson M, Dircksen C, Vetzel M, Kleindl P, Santhapuram H, Vlahov IR, Leamon CP. Reddy JA, et al. Among authors: vetzel m. Sci Rep. 2018 Jun 12;8(1):8943. doi: 10.1038/s41598-018-27320-5. Sci Rep. 2018. PMID: 29895863 Free PMC article.

2

Prostate-Specific Membrane Antigen-Specific Antitumor Activity of a Self-Immolative Tubulysin Conjugate.

Leamon CP, Reddy JA, Bloomfield A, Dorton R, Nelson M, Vetzel M, Kleindl P, Hahn S, Wang K, Vlahov IR. Leamon CP, et al. Among authors: vetzel m. Bioconjug Chem. 2019 Jun 19;30(6):1805-1813. doi: 10.1021/acs.bioconjchem.9b00335. Epub 2019 May 22. Bioconjug Chem. 2019. PMID: 31075200

3

Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent.

Reddy JA, Nelson M, Dircksen C, Vetzel M, Johnson T, Cross V, Westrick E, Qi L, Hahn S, Santhapuram HK, Parham G, Wang K, Vaughn JF, Felten A, Pugh M, Lu J, Klein P, Vlahov IR, Leamon CP. Reddy JA, et al. Among authors: vetzel m. Sci Rep. 2020 Jul 29;10(1):12772. doi: 10.1038/s41598-020-69682-9. Sci Rep. 2020. PMID: 32728172 Free PMC article.

4

Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.

Leamon CP, Vlahov IR, Reddy JA, Vetzel M, Santhapuram HK, You F, Bloomfield A, Dorton R, Nelson M, Kleindl P, Vaughn JF, Westrick E. Leamon CP, et al. Among authors: vetzel m. Bioconjug Chem. 2014 Mar 19;25(3):560-8. doi: 10.1021/bc400441s. Epub 2014 Mar 11. Bioconjug Chem. 2014. PMID: 24564229

5

Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates.

Vlahov IR, Qi L, Kleindl PJ, Santhapuram HK, Felten A, Parham GL, Wang K, You F, Vaughn JF, Hahn SJ, Klein HF, Vetzel M, Reddy JA, Nelson M, Nicoson J, Leamon CP. Vlahov IR, et al. Among authors: vetzel m. Bioconjug Chem. 2017 Dec 20;28(12):2921-2931. doi: 10.1021/acs.bioconjchem.7b00476. Epub 2017 Dec 6. Bioconjug Chem. 2017. PMID: 29211454

6

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.

Reddy JA, Dorton R, Westrick E, Dawson A, Smith T, Xu LC, Vetzel M, Kleindl P, Vlahov IR, Leamon CP. Reddy JA, et al. Among authors: vetzel m. Cancer Res. 2007 May 1;67(9):4434-42. doi: 10.1158/0008-5472.CAN-07-0033. Cancer Res. 2007. PMID: 17483358

7

Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies.

Lu YJ, Chu H, Wheeler LW, Nelson M, Westrick E, Matthaei JF, Cardle II, Johnson A, Gustafson J, Parker N, Vetzel M, Xu LC, Wang EZ, Jensen MC, Klein PJ, Low PS, Leamon CP. Lu YJ, et al. Among authors: vetzel m. Front Oncol. 2019 Mar 19;9:151. doi: 10.3389/fonc.2019.00151. eCollection 2019. Front Oncol. 2019. PMID: 30941303 Free PMC article.

8

Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.

Reddy JA, Dorton R, Bloomfield A, Nelson M, Vetzel M, Guan J, Leamon CP. Reddy JA, et al. Among authors: vetzel m. Clin Cancer Res. 2014 Apr 15;20(8):2104-14. doi: 10.1158/1078-0432.CCR-13-2423. Epub 2014 Jan 15. Clin Cancer Res. 2014. PMID: 24429878

9

High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.

Guertin AD, O'Neil J, Stoeck A, Reddy JA, Cristescu R, Haines BB, Hinton MC, Dorton R, Bloomfield A, Nelson M, Vetzel M, Lejnine S, Nebozhyn M, Zhang T, Loboda A, Picard KL, Schmidt EV, Dussault I, Leamon CP. Guertin AD, et al. Among authors: vetzel m. Mol Cancer Ther. 2016 Aug;15(8):1998-2008. doi: 10.1158/1535-7163.MCT-15-0950. Epub 2016 Jun 2. Mol Cancer Ther. 2016. PMID: 27256377

10

Preclinical antitumor activity of a novel folate-targeted dual drug conjugate.

Leamon CP, Reddy JA, Vlahov IR, Westrick E, Dawson A, Dorton R, Vetzel M, Santhapuram HK, Wang Y. Leamon CP, et al. Among authors: vetzel m. Mol Pharm. 2007 Sep-Oct;4(5):659-67. doi: 10.1021/mp070049c. Epub 2007 Sep 18. Mol Pharm. 2007. PMID: 17874843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year